SOPHiA GENETICS S.A.
SOPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 4.5% | 31.1% | 17.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 67.4% | 68.8% | 65.7% | 62.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -77.9% | -111.5% | -171.1% | -171.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -95.9% | -126.6% | -183.9% | -182.1% |
| EPS Diluted | -0.95 | -1.22 | -1.36 | -1.33 |
| % Growth | 22.1% | 10.3% | -2.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |